USA - NASDAQ:AUGX - US05105P1075 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to AUGX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-22 | Lake Street | Downgrade | Buy -> Hold |
| 2024-05-14 | Lake Street | Maintains | Buy -> Buy |
| 2024-05-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-04-09 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2024-04-03 | B. Riley Securities | Reiterate | Buy |
| 2024-03-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-03-19 | Maxim Group | Maintains | Buy -> Buy |
| 2023-12-15 | Evercore ISI Group | Initiate | In-Line |
| 2023-05-16 | Benchmark | Reiterate | Buy -> Buy |
| 2023-05-15 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-04-21 | Benchmark | Maintains | Buy |
| 2023-04-21 | Maxim Group | Maintains | Buy |
| 2023-04-20 | B. Riley Securities | Reiterate | Buy |
| 2023-03-31 | Benchmark | Reiterate | Buy |
| 2023-03-28 | Maxim Group | Maintains | Buy |
| 2022-03-07 | Lake Street | Initiate | Buy |
| 2022-01-21 | Maxim Group | Initiate | Buy |
| 2021-11-01 | William Blair | Initiate | Outperform |
| 2021-11-01 | Benchmark | Initiate | Buy |
10 analysts have analysed AUGX and the average price target is 3.6 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 2.35.
The consensus rating for AUGMEDIX INC (AUGX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering AUGMEDIX INC (AUGX) is 10.